vanadates has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araullo-Cruz, T; Berman, J; Gordon, YJ; Lin, LS; Romanowski, E; Schlessinger, D; Vikoren, P | 1 |
| Cai, G; Friedman, E; Torres, C; Zhen, X | 1 |
| Dankowski, A; Hagg, T; Yang, P | 1 |
3 other study(ies) available for vanadates and oxidopamine
| Article | Year |
|---|---|
Vanadate promotes reactivation and iontophoresis-induced ocular shedding of latent HSV-1 W in different host animals.
Topics: Animals; Cells, Cultured; Chi-Square Distribution; Cornea; Epinephrine; Eye; Female; Hydroxydopamines; Iontophoresis; Male; Mice; Mice, Inbred BALB C; Oxidopamine; Rabbits; Simplexvirus; Tears; Trigeminal Ganglion; Vanadates; Vero Cells; Virus Activation; Virus Cultivation | 1990 |
Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Oxidopamine; Parkinson Disease; PC12 Cells; Phosphorylation; Protein Tyrosine Phosphatases; Quinpirole; Rats; Receptors, Dopamine D2; Sympatholytics; Tyrosine; Vanadates | 2002 |
Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6-OHDA treated adult rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gene Expression; Nerve Degeneration; Nerve Growth Factors; Neurons; Oxidopamine; Phosphorylation; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley; Stilbamidines; Substantia Nigra; Tyrosine 3-Monooxygenase; Vanadates | 2007 |